Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Disseminated fusariosis during acute myelogenous leukemia induction treatment.

Mehta A, Bellam N.

Blood. 2014 May 29;123(22):3379. doi: http://dx.doi.org/10.1182/blood-2014-02-556654. No abstract available.

2.

Phase 1b study of otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIRâ„¢ therapeutic protein, in combination with rituximab and bendamustine in relapsed indolent lymphoma patients.

Gopal AK, Tarantolo SR, Bellam N, Green DJ, Griffin M, Feldman T, Mato AR, Eisenfeld AJ, Stromatt SC, Goy A.

Invest New Drugs. 2014 Dec;32(6):1213-25. doi: 10.1007/s10637-014-0125-2. Epub 2014 Jun 15.

3.

Non-Hodgkin's lymphomas, version 2.2014.

Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Bellam N, Byrd JC, Czuczman MS, Fayad LE, Fisher RI, Glenn MJ, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Sokol L, Swinnen LJ, Tsien C, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H.

J Natl Compr Canc Netw. 2014 Jun;12(6):916-46.

PMID:
24925202
4.

Non-Hodgkin's lymphomas, version 1.2013.

Zelenetz AD, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Bellam N, Byrd JC, Czuczman MS, Fayad LE, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Nademanee A, Porcu P, Press O, Pro B, Reddy N, Sokol L, Swinnen L, Tsien C, Vose JM, Yahalom J, Zafar N, Dwyer MA, Naganuma M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 Mar 1;11(3):257-72; quiz 273.

PMID:
23486452
5.

Non-Hodgkin's Lymphomas, version 3.2012.

Zelenetz AD, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Bellam N, Byrd JC, Czuczman MS, Fayad L, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Nademanee A, Porcu P, Press O, Pro B, Reddy N, Sokol L, Swinnen L, Tsien C, Vose JM, Yahalom J, Zafar N, Naganuma M, Dwyer MA.

J Natl Compr Canc Netw. 2012 Dec 1;10(12):1487-98.

PMID:
23221787
6.

Acute lymphoblastic leukemia.

Alvarnas JC, Brown PA, Aoun P, Ballen KK, Bellam N, Blum W, Boyer MW, Carraway HE, Coccia PF, Coutre SE, Cultrera J, Damon LE, DeAngelo DJ, Douer D, Frangoul H, Frankfurt O, Goorha S, Millenson MM, O'Brien S, Petersdorf SH, Rao AV, Terezakis S, Uy G, Wetzler M, Zelenetz AD, Naganuma M, Gregory KM; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Jul 1;10(7):858-914.

PMID:
22773801
7.

Non-Hodgkin's lymphomas.

Zelenetz AD, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Bellam N, Byrd JC, Czuczman MS, Fayad LE, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, LaCasce AS, Nademanee A, Porcu P, Press O, Pro B, Reddy N, Sokol L, Swinnen LJ, Tsien C, Vose JM, Wierda WG, Yahalom J, Zafar N.

J Natl Compr Canc Netw. 2011 May;9(5):484-560. No abstract available.

PMID:
21550968
8.

Tgf-beta signaling alterations and colon cancer.

Bellam N, Pasche B.

Cancer Treat Res. 2010;155:85-103. doi: 10.1007/978-1-4419-6033-7_5. Review.

PMID:
20517689
9.

Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs.

Pasche B, Wisinski KB, Sadim M, Kaklamani V, Pennison MJ, Zeng Q, Bellam N, Zimmerman J, Yi N, Zhang K, Baron J, Stram DO, Hayes MG.

J Exp Clin Cancer Res. 2010 May 25;29:57. doi: 10.1186/1756-9966-29-57.

10.

14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer.

Wang B, Liu K, Lin HY, Bellam N, Ling S, Lin WC.

Mol Cell Biol. 2010 Mar;30(6):1508-27. doi: 10.1128/MCB.01335-09. Epub 2010 Jan 19.

11.

Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer.

Liu K, Bellam N, Lin HY, Wang B, Stockard CR, Grizzle WE, Lin WC.

Mol Cell Biol. 2009 May;29(10):2673-93. doi: 10.1128/MCB.01140-08. Epub 2009 Mar 16.

12.

Strategies to enhance patient adherence: making it simple.

Atreja A, Bellam N, Levy SR.

MedGenMed. 2005 Mar 16;7(1):4.

Supplemental Content

Loading ...
Support Center